Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Responds to CMS Proposed Rule for CY 2022 PFS and Other Policy Changes (NCD 180.2)
-
ACMG Letter of Support for the Expanded Genetic Screening Act
-
ACMG Letter to Congress about Medicaid Coverage of Genetic and Genomic Testing
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Testimony in Support of the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)